Page last updated: 2024-12-08

cyanoginosin lr

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cyanoginosin LR: cyclic heptapeptide from cyanobacterium Microcystis aeruginosa [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

microcystin-LR : A microcystin consisting of D-alanyl, L-leucyl, (3S)-3-methyl-D-beta-aspartyl,L-arginyl, 2S,3S,4E,6E,8S,9S)-3-amino-4,5,6,7-tetradehydro-9-methoxy-2,6,8-trimethyl-10-phenyldecanoyl, D-gamma-glutamyl, and 2,3-didehydro-N-methylalanyl residues joined into a 25-membered macrocycle. Produced by the cyanobacterium Microcystis aeruginosa, it is the most studied of the microcystins. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID445434
CHEMBL ID444092
CHEBI ID6925
SCHEMBL ID21245230
MeSH IDM0161701

Synonyms (51)

Synonym
toxin, blue green alga, microcystis aeruginosa
toxin t 17 (microcystis aeruginosa)
microcystin-a
cyanoginosin la, 5-l-arginine-
5-l-argininecyanoginosin la
toxin i (microcystis aeruginosa)
akerstox
brn 4779759
101043-37-2
C05371 ,
microcystin-lr
microcystin lr
mcyst-lr
nsc733608
nsc-733608
5-l-arginine-microcystin la
mclr
microcystin-la, 5-l-arginine-
toxin t-17 (microcystis aeruginosa)
toxin i, cyanobacterium
cyanoginosin-lr
cyclo(ala-leu-masp-arg-adda-isoglu-mdha)
1,7-anhydro[d-alanyl-l-leucyl-(3s)-3-methyl-d-beta-aspartyl-l-arginyl-(2s,3s,4e,6e,8s,9s)-3-amino-4,5,6,7-tetradehydro-9-methoxy-2,6,8-trimethyl-10-phenyldecanoyl-d-gamma-glutamyl-2,3-didehydro-n-methylalanine]
CHEBI:6925 ,
microcystis aeruginosa toxin
cyclo[2,3-didehydro-n-methylalanyl-d-alanyl-l-leucyl-erythro-3-methyl-d-beta-aspartyl-l-arginyl-(2s,3s,4e,6e,8s,9s)-3-amino-4,5,6,7-tetradehydro-9-methoxy-2,6,8-trimethyl-10-phenyldecanoyl-d-gamma-glutamyl]
cyclo[d-alanyl-l-leucyl-(3s)-3-methyl-d-beta-aspartyl-l-arginyl-(2s,3s,4e,6e,8s,9s)-3-amino-4,5,6,7-tetradehydro-9-methoxy-2,6,8-trimethyl-10-phenyldecanoyl-d-gamma-glutamyl-2,3-didehydro-n-methylalanyl]
cyanoginosin lr
toxin-lr
(5r,8s,11r,12s,15s,18s,19s,22r)-15-[3-(diaminomethylideneamino)propyl]-18-[(1e,3e,5s,6s)-6-methoxy-3,5-dimethyl-7-phenylhepta-1,3-dienyl]-1,5,12,19-tetramethyl-2-methylidene-8-(2-methylpropyl)-3,6,9,13,16,20,25-heptaoxo-1,4,7,10,14,17,21-heptazacyclopenta
CHEMBL444092 ,
bdbm50061067
15-(3-guanidino-propyl)-8-isobutyl-18-(6-methoxy-3,5-dimethyl-7-phenyl-hepta-1,3-dienyl)-1,5,12,19-tetramethyl-2-methylene-3,6,9,13,16,20,25-heptaoxo-1,4,7,10,14,17,21heptaaza-cyclopentacosane-11,22-dicarboxylic acid
15-(3-guanidino-propyl)-8-isobutyl-18-((1e,3e)-6-methoxy-3,5-dimethyl-7-phenyl-hepta-1,3-dienyl)-1,5,12,19-tetramethyl-2-methylene-3,6,9,13,16,20,25-heptaoxo-1,4,7,10,14,17,21heptaaza-cyclopentacosane-11,22-dicarboxylic acid
8-[3-amino(imino)methylaminopropyl]-15-isobutyl-5-[6-methoxy-3,5-dimethyl-7-phenyl-(1e,3e)-1,3-heptadienyl]-4,11,18,22-tetramethyl-21-methylene-3,7,10,14,17,20,23-heptaoxo-2,6,9,13,16,19,22-heptaazacyclopentacosane-1,12-dicarboxylic acid
hsdb 7751
eq8332842y ,
unii-eq8332842y
nsc 733608
gtpl4735
microcystin-lr [hsdb]
microcystin-lr [iarc]
cyclo(2,3-didehydro-n-methylalanyl-d-alanyl-l-leucyl-(3s)-3-methyl-d-.beta.-aspartyl-l-arginyl-(2s,3s,4e,6e,8s,9s)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyl-4,6-decadienoyl-d-.gamma.-glutamyl)
1,7-anhydro(d-alanyl-l-leucyl-(3s)-3-methyl-d-.beta.-aspartyl-l-arginyl-(2s,3s,4e,6e,8s,9s)-3-amino-4,5,6,7-tetradehydro-9-methoxy-2,6,8-trimethyl-10-phenyldecanoyl-d-.gamma.-glutamyl-2,3-didehydro-n-methylalanine)
cyclo(2,3-didehydro-n-methylalanyl-d-alanyl-l-leucyl-erythro-3-methyl-d-.beta.-aspartyl-l-arginyl-(2s,3s,4e,6e,8s,9s)-4,5,6,7-tetradehydro-9-methoxy-2,6,8-trimethyl-10-phenyl-3-aminodecanoyl-d-.gamma.-glutamyl)
DTXSID3031654
HY-P0072
CS-5404
cyanoginosin-lr;mc-lr;toxin t 17 (microcystis aeruginosa)
Q6839436
SCHEMBL21245230

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"The recent rise in the awareness of the occurrence of toxic cyanobacterial blooms in aquatic environments, with associated human health problems and animal deaths, has increased the need for rapid, reliable and sensitive methods of determining cyanobacterial toxicity."( Use of a rapid bioluminescence assay for detecting cyanobacterial microcystin toxicity.
Beattie, KA; Campbell, DL; Codd, GA; Lawton, LA, 1990
)
0.28
" Toxic blooms of this cyanobacteria have been reported throughout the temperate world."( Evaluation of potential chemoprotectants against microcystin-LR hepatotoxicity in mice.
Eldeen, ZM; Hermansky, SJ; Mereish, KA; Roche, VF; Stohs, SJ, 1991
)
0.28
" Many toxic effects of microcystin in the perfused liver mimicked those observed in the whole animal, suggesting that this model can be used as an alternative to whole animals for screening of potential therapeutic agents."( Toxicity and kinetics of [3H]microcystin-LR in isolated perfused rat livers.
Geisbert, TW; Matson, CF; Miura, GA; Pace, JG; Robinson, NA; White, JD, 1991
)
0.28
"Microcystins and nodularin, isolated from toxic blue-green algae, are hepatotoxic monocyclic polypeptides."( Inhibition of protein phosphatases by microcystins and nodularin associated with hepatotoxicity.
Carmichael, WW; Fujiki, H; Harada, K; Ichihara, A; Matsushima, R; Watanabe, MF; Yoshizawa, S, 1990
)
0.28
" We have shown that cyclosporin A (CsA) can prevent the toxic and lethal effects of MCLR in mice."( Cyclosporin A--a chemoprotectant against microcystin-LR toxicity.
Casey, PJ; Hermansky, SJ; Stohs, SJ, 1990
)
0.28
"The toxic effects of microcystin-LR, a cyclic heptapeptide isolated from the cyanobacterium Microcystis aeruginosa, were studied in the fasted rat model and in subcellular fractions from fasted, toxin-treated and control rats."( Comparison of in vivo and in vitro toxic effects of microcystin-LR in fasted rats.
Bostian, KA; Geisbert, TW; Miura, GA; Pace, JG; Robinson, NA; White, JD, 1989
)
0.28
" This system was employed for toxicity screening of five algal species of Indian origin on the basis of the EC50 for LDH leakage (dose of cyanobacteria resulting in leakage of 50% of enzyme) of a known toxic cyanobacterial strain Microcystis aeruginosa (PCC 7820)."( Liver slice culture for assessing hepatotoxicity of freshwater cyanobacteria.
Bhaskar, AS; Bhattacharya, R; Dube, SN; Pant, SC; Rao, PV, 1996
)
0.29
" The results of this work were as follows: (1) Microcystin-LR is 30-100 times less toxic via oral ingestion than via intraperitoneal injection; (2) Microcystin-LR is not a selective developmental toxicant in the mouse."( The toxicity of cyanobacterial toxins in the mouse: I microcystin-LR.
Everett, DJ; Fawell, JK; Hill, RE; Mitchell, RE, 1999
)
0.3
"5 times more toxic than MC-LR."( Comparative toxicity of four microcystins of different hydrophobicities to the protozoan, Tetrahymena pyriformis.
Codd, GA; Ward, CJ, 1999
)
0.3
" Assessment of cell viability using colorimetric 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays indicated that purified microcystin-LR induced toxic effect on KB and H-4-II-E cell lines after 96 h incubation at toxin concentrations greater than 18."( Study on the cytotoxicity of microcystin-LR on cultured cells.
Chong, MW; Fong, WF; Gu, KD; Lam, PK; Yang, M, 2000
)
0.31
"We have shown previously that exposure to microcystin-LR (MCLR) causes renal toxic effects in isolated perfused rat kidney."( The role of phospholipase A(2) and cyclooxygenase in renal toxicity induced by microcystin-LR.
Angelim, EV; Coêlho, GR; Coutinho, MC; Fonteles, MC; Menezes, DB; Monteiro, HS; Nobre, AC; Silva, MM, 2001
)
0.31
"Planktothrix rubescens, the dominant cyanobacterium in Lake Zürich, is generally considered to be toxic to zooplankton."( High grazer toxicity of [D-Asp(3),(E)-Dhb(7)]microcystin-RR of Planktothrix rubescens as compared to different microcystins.
Blom, JF; Jüttner, F; Robinson, JA, 2001
)
0.31
" Microcystin-LR, cylindrospermopsin and lophyrotomin all exhibited toxic effects on the primary rat hepatocytes with 72-h LC(50) of 8, 40 and 560 ng/ml, respectively."( Toxicity and uptake mechanism of cylindrospermopsin and lophyrotomin in primary rat hepatocytes.
Chong, MW; Lam, PK; Seawright, AA; Shaw, GR; Wong, BS, 2002
)
0.31
"Two metabolites of microcystin-LR glutathione conjugate and, microcystin-cysteine conjugate, as well as microcystin-RR (MCRR) are less toxic than microcystin-LR (MCLR)."( Comparison of protein phosphatase inhibitory activity and apparent toxicity of microcystins and related compounds.
Harada, K; Imanishi, S; Ito, E; Kondo, F; Masui, H; Takai, A, 2002
)
0.31
"To assess Microcystin LR (MCLR)-induced acute toxic effects in male Sprague-Dawley rats."( [The acute toxic effects of microcystin LR in SD rats].
Chen, C; Kang, S; Wei, G; Yu, S; Zhang, Z, 2002
)
0.31
"These results suggested that MCLR can injure the heart, kidney and the liver in SD rats, and there is a dose-response relationship between MCLR and the toxic effect."( [The acute toxic effects of microcystin LR in SD rats].
Chen, C; Kang, S; Wei, G; Yu, S; Zhang, Z, 2002
)
0.31
" Recently, toxic Microcystis blooms frequently occur in the eutrophic Dianchi Lake (300 km2 and located in the South-Western of China)."( Responses of antioxidant systems in the hepatocytes of common carp (Cyprinus carpio L.) to the toxicity of microcystin-LR.
Li, X; Liu, J; Liu, Y; Song, L, 2003
)
0.32
" The grazing ability of silver carp on toxic cyanobacteria suggests an applicability of using phytoplanktivorous fish to counteract cyanotoxin contamination in eutrophic waters."( Dynamics of microcystins-LR and -RR in the phytoplanktivorous silver carp in a sub-chronic toxicity experiment.
Honma, T; Ozawa, K; Park, HD; Xie, L; Xie, P; Yokoyama, A, 2004
)
0.32
"Microcystins are naturally occurring hepatotoxins produced by certain strains of Microcystis aeruginosa and microcystin-LR is the most toxic among the 60 microcystin variants isolated so far."( Age-dependent effects on biochemical variables and toxicity induced by cyclic peptide toxin microcystin-LR in mice.
Bhaskar, AS; Gupta, N; Jatav, PC; Jayaraj, R; Rao, PV, 2005
)
0.33
" At the same time, we also found that the LDH activity in test animals increased with exposure to microcystin-LR, indicating that adverse effects occurred in Daphnia."( Chronic toxicity and responses of several important enzymes in Daphnia magna on exposure to sublethal microcystin-LR.
Chen, W; Gan, N; Ou, D; Song, L, 2005
)
0.33
" Microcystins produced by certain genera of cyanobacteria can affect public health in this area because of their acute and chronic toxic effects."( Evaluating genotoxicity associated with microcystin-LR and its risk to source water safety in Meiliang Bay, Taihu Lake.
Gao, G; Shen, JH; Wu, JY; Xu, QJ, 2006
)
0.33
"Purified cyanobacterial lipopolysaccharide (LPS) was not acutely toxic to three aquatic invertebrates (Artemia salina, Daphnia magna and Daphnia galeata) in immersion trials."( Protection against the toxicity of microcystin-LR and cylindrospermopsin in Artemia salina and Daphnia spp. by pre-treatment with cyanobacterial lipopolysaccharide (LPS).
Codd, GA; Lindsay, J; Metcalf, JS, 2006
)
0.33
"Unchlorinated treated waters from two Australian reservoirs were spiked with microcystin-LA and -LR extracted from a toxic scum of Microcystis aeruginosa."( Decrease in toxicity of microcystins LA and LR in drinking water by ozonation.
Brooke, S; Klass, G; Newcombe, G; Nicholson, B, 2006
)
0.33
" Previous studies have demonstrated that chlorine and potassium permanganate are feasible oxidants for the removal of MCs present in drinking water resources, although the oxidation might lead to toxic oxidation products."( Oxidation of MC-LR and -RR with chlorine and potassium permanganate: toxicity of the reaction products.
Acero, JL; Meriluoto, J; Rodríguez, EM; Spoof, L, 2008
)
0.35
" Oatp1b2-null mice are useful in elucidating the role of Oatp1b2 and its human orthologs OATP1B1/1B3 in hepatic uptake and systemic disposition of toxic chemicals and therapeutic drugs."( Characterization of organic anion transporting polypeptide 1b2-null mice: essential role in hepatic uptake/toxicity of phalloidin and microcystin-LR.
Cheng, X; Choudhuri, S; Csanaky, IL; Klaassen, CD; Lei, X; Lu, H; Ogura, K; Song, PZ, 2008
)
0.35
"The aim of this study was to investigate whether microcystin-LR, one of the most common cyanobacterial toxins has toxic effects on reproductive system in vivo or Leydig cells in vitro."( The toxic effects of microcystin-LR on the reproductive system of male rats in vivo and in vitro.
Han, X; Li, Y; Sha, J; Sheng, J,
)
0.13
"This study investigates the toxicity and post-exposure effects of dissolved microcystin (MC-LR) on the dominant copepods of the upper San Francisco Estuary (SFE), where blooms of the toxic cyanobacteria Microcystis aeruginosa coincide with record low levels in the abundance of pelagic organisms including phytoplankton, zooplankton, and fish."( Microcystin-LR toxicity on dominant copepods Eurytemora affinis and Pseudodiaptomus forbesi of the upper San Francisco Estuary.
Ger, KA; Goldman, CR; Teh, SJ, 2009
)
0.35
"Microcystins (MCs) are toxins of heptapeptidic structure produced by toxic cyanobacteria in surface eutrophic waters."( Microcystin-LR induces toxic effects in differentiated and undifferentiated Caco-2 cells.
Cameán, AM; Jos, A; Pichardo, S; Puerto, M, 2010
)
0.36
" It allowed identification of toxic samples and quantification of both nonspecific and MC-LR type of toxicity."( Mitochondrial toxicity of microcystin-LR on cultured cells: application to the analysis of contaminated water samples.
Bláha, L; Davenport, J; Jasionek, G; Papkovsky, DB; Zhdanov, A, 2010
)
0.36
" An understanding of structure-activity relationships (SARs) of chemicals can make a significant contribution to the identification of potential toxic effects early in the drug development process and aid in avoiding such problems."( Developing structure-activity relationships for the prediction of hepatotoxicity.
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ, 2010
)
0.36
" The LD50 values evidently increased with a decline of the temperature (547, 260 and 176 µg kg⁻¹ at 12, 22 and 32 °C, respectively), indicating stronger tolerance of the fish at lower temperatures."( Studies on the toxic effects of microcystin-LR on the zebrafish (Danio rerio) under different temperatures.
Ji, W; Xie, P; Zhang, H; Zhang, W; Zhang, X, 2011
)
0.37
" In conclusion, our results suggest that NO and SP are free of MC and the long-term dietary supplementation of up to 5% of the BGA may be consumed without evident toxic side-effects."( In vitro and in vivo safety assessment of edible blue-green algae, Nostoc commune var. sphaeroides Kützing and Spirulina plantensis.
Cassada, DA; Lee, J; Park, Y; Rogers, DG; Snow, DD; Yang, Y, 2011
)
0.37
" In the present study, we investigated membrane transport of MC-LR and its toxic effects on zebrafish embryos using fragmentation of embryos, scanning electron microscope (SEM), fluorescence microscopy, and toxic exposure tests."( Transmembrane transport of microcystin to Danio rerio zygotes: insights into the developmental toxicity of environmental contaminants.
Gao, HW; Song, C; Wu, LL, 2011
)
0.37
" The most toxic and widely distributed MC is microcystin-LR (MC-LR)."( Microcystin-LR causes cytotoxicity effects in rat testicular Sertoli cells.
Han, X; Li, Y, 2012
)
0.38
" We examined whether MC-LR could enter spermatogonia and investigated the toxic effects of MC-LR on spermatogonia in vitro."( The toxic effects of microcystin-LR on rat spermatogonia in vitro.
Han, X; Wu, J; Yuan, J; Zhou, Y, 2012
)
0.38
"This study aims to demonstrate that microcystin-LR (MC-LR) has toxic effects on the reproductive system of male Rana nigromaculata in vitro."( Toxic effects of microcystin-LR on the reproductive system of male Rana nigromaculata in vitro.
Cai, C; Han, L; Jia, X; Shou, X; Wang, J; Wang, M; Wu, Y; Ye, B; Zhang, H, 2013
)
0.39
"Blooms of cyanobacteria producing very toxic secondary metabolites (especially microcystins) are potent environmental stressors, hazardous not only to aquatic animals but also to public health."( Cytotoxic effects and changes in cytokine gene expression induced by microcystin-containing extract in fish immune cells--an in vitro and in vivo study.
Adaszek, Ł; Rymuszka, A, 2013
)
0.39
" These results indicated that MCLR could induce toxic effects on the reproductive system of frogs, significantly decrease testosterone content, and rapidly increase estradiol content."( Endocrine-disrupting effects and reproductive toxicity of low dose MCLR on male frogs (Rana nigromaculata) in vivo.
Cai, C; Gao, N; Jia, X; Wang, J; Zhang, H, 2014
)
0.4
" MCs exposure exerts great harm to the reproductive system of fish and deteriorates the quality of eggs and sperms, and has further adverse effects on early developmental stages of fish."( Microcystin-LR exposure to adult zebrafish (Danio rerio) leads to growth inhibition and immune dysfunction in F1 offspring, a parental transmission effect of toxicity.
Chen, Y; Liu, W; Qiao, Q; Wu, K; Zhang, X, 2014
)
0.4
" The results indicated that pressure enhanced coagulation is a safe and reliable method for Cyanobacteria removal."( [Microcystin safety study during Cyanobacteria removal by pressure enhanced coagulation process].
Cong, HB; Jiang, XY; Liu, YJ; Luan, Q; Xu, ST; Zhu, XY, 2014
)
0.4
" Microcystins induce a variety of toxic cellular effects, including oxidative damage, apoptosis, cytoskeletal destabilization, and cancer cell invasion."( The role of PP2A-associated proteins and signal pathways in microcystin-LR toxicity.
Liu, J; Sun, Y, 2015
)
0.42
" Using the model of Xenopus laevis embryos, we test the hypothesis that combined exposure of amphibians to natural toxins and anthropogenic pollutants induces more pronounced adverse effects than single exposures."( Mixture toxicity of microcystin-LR, paraoxon and bromadiolone in Xenopus laevis embryos.
Bandouchova, H; Hilscherova, K; Kovacova, V; Linhart, P; Miksikova, M; Mlcakova, V; Ondracek, K; Osickova, J; Pikula, J; Pohanka, M; Skochova, H, 2015
)
0.42
"This study helps to understand adverse effects of environmental pollution by natural toxins and agrochemicals in amphibians."( Mixture toxicity of microcystin-LR, paraoxon and bromadiolone in Xenopus laevis embryos.
Bandouchova, H; Hilscherova, K; Kovacova, V; Linhart, P; Miksikova, M; Mlcakova, V; Ondracek, K; Osickova, J; Pikula, J; Pohanka, M; Skochova, H, 2015
)
0.42
"Microcystins (MCs) are hepatotoxic cyclic peptides, and microcystin-LR (MCLR) is one of the most abundant and toxic congeners."( An Overview of the Mechanisms of Microcystin-LR Genotoxicity and Potential Carcinogenicity.
Zegura, B, 2016
)
0.43
" In conclusion, we demonstrate here a crucial role for miR-541 in MC-LR-induced toxic effects on the reproductive system, in an attempt to provide a rational strategy for the diagnosis and treatment of MC-LR-induced impairment in the reproductive system."( miR-541 Contributes to Microcystin-LR-Induced Reproductive Toxicity through Regulating the Expression of p15 in Mice.
Chen, X; Han, X; Li, D; Meng, X; Xiang, Z; Zhang, L, 2016
)
0.43
" In order to understand the development of their neurotoxicity we investigated the toxic effects of MC variants, MC-LR, MC-LW and MC-LF, in astrocytes that play a central role in maintaining brain homeostasis."( Selective cytotoxicity of microcystins LR, LW and LF in rat astrocytes.
Bulc Rozman, K; Jurič, DM; Šuput, D, 2017
)
0.46
" More than 100 microcystin analogues have been detected, among which microcystin-LR is the most abundant and toxic variant."( Amelioratory effect of coenzyme Q10 on potential human carcinogen Microcystin-LR induced toxicity in mice.
Bhide, M; Koiri, RK; Lone, Y, 2017
)
0.46
" In the present study, primarily cultured rat hepatocytes were used to systematically investigate hepatotoxic characteristics of MC-LR (one of the most abundant and toxic MCs variants)."( Characterization of Microcystin-Induced Dualistic Toxic Effects on Primary Rat Hepatocytes.
Hong, X; Lou, D; Qian, X; Shuai, Y; Wang, Y; Xiao, P; Yin, J; Zhong, W, 2017
)
0.46
" We regard these adverse effects as a parental transgenerational toxicity of MCLR."( Parental exposure to microcystin-LR induced thyroid endocrine disruption in zebrafish offspring, a transgenerational toxicity.
Cheng, H; Gong, X; Hung, TC; Li, G; Liu, C; Wu, Q; Yan, W, 2017
)
0.46
" The bloom was dominated by potentially toxic species: Planktothrix agardhii, Limnothrix redekei, and Aphanizomenon gracile."( The structure and toxicity of winter cyanobacterial bloom in a eutrophic lake of the temperate zone.
Kokociński, M; Meriluoto, J; Rzymski, P; Wejnerowski, Ł, 2018
)
0.48
" Research on oxidative stress showed that both regulation pathways could reduce the formation of reactive oxygen species (stimulated by MCLR and regulated by NADH oxidase) and regulate the adverse effects on antioxidant enzymes."( Evaluation of the Direct and Indirect Regulation Pathways of Glutathione Target to the Hepatotoxicity of Microcystin-LR.
Du, YG; Liu, YZ; Teng, Y; Wang, Q; Zhang, SH; Zong, WS, 2018
)
0.48
"The vast majority of studies measure the toxic effect of organisms exposed to nanoparticles (NPs) while there is still a lack of knowledge about the influence of NPs on the aquatic environment."( Environmental risks of ZnO nanoparticle exposure on Microcystis aeruginosa: Toxic effects and environmental feedback.
Guo, M; Malkoske, T; Tang, Y; Xia, S; Xin, H; Yang, S; Yin, D, 2018
)
0.48
" This amplified toxic action can be related to a synergistic effect between the MCLR and other compounds present in the environmental samples."( Genetic toxicity of water contaminated by microcystins collected during a cyanobacteria bloom.
Gonçalves, LC; Marin-Morales, MA; Pamplona-Silva, MT, 2018
)
0.48
" Thereafter the pretreated and non-pretreated Sertoli cells were cultured in medium containing 10% heat-activated fetal bovine serum + 80 μg/L MC-LR for 24 hours to assess the ability of TLR4-IN-C34 to attenuate the toxic effects of MC-LR."( Pharmacological inhibition of TLR4/NF-κB with TLR4-IN-C34 attenuated microcystin-leucine arginine toxicity in bovine Sertoli cells.
Adegoke, EO; Adeniran, SO; Wang, C; Wang, H; Wang, X; Zeng, Y; Zhang, G; Zhang, H; Zheng, P, 2019
)
0.51
" Therefore, CysGO-MlrA might be used as an efficient and ecologically safe degradation material for NOD."( Effect of the immobilized microcystin-LR-degrading enzyme MlrA on nodularin degradation and its immunotoxicity study.
Gu, X; Sheng, Q; Wu, H; Wu, X; Ye, J; Zhang, R, 2020
)
0.56
" To assess the toxic effects of anatoxin-a, microcystin-LR and their combined exposure on submerged macrophytes and biofilms, Vallisneria natans was exposed to solutions containing different concentrations of anatoxin-a and microcystin-LR (0."( Combined toxic effects of anatoxin-a and microcystin-LR on submerged macrophytes and biofilms.
Gu, P; Li, Q; Luo, X; Zhang, C; Zhang, H; Zhang, J; Zheng, Z, 2020
)
0.56
" The guidelines for MC-LR safe exposure limits have been previously established based on healthy animal studies, however we have previously demonstrated that pre-existing non-alcoholic fatty liver disease (NAFLD) increases susceptiblity to the hepatotoxic effects of MC-LR."( Assessment of diagnostic biomarkers of liver injury in the setting of microcystin-LR (MC-LR) hepatotoxicity.
Breidenbach, JD; Haller, ST; Kennedy, DJ; Kleinhenz, AL; Lad, A; Malhotra, D; Modyanov, N; Su, RC, 2020
)
0.56
" In this study, the single and mixture toxic effects of MC-LR and Phe mixtures were investigated in Daphnia magna after acute and chronic exposure."( Acute and chronic toxicity of microcystin-LR and phenanthrene alone or in combination to the cladoceran (Daphnia magna).
Cheng, C; Gu, Y; Shu, X; Wan, X; Xie, L; Zhao, Y, 2021
)
0.62
"These results suggest that the GO-MCLR complex formed by GO adsorption of MCLR may exhibit more toxic effects than the single material, which demonstrates the necessity for assessing nano-toxicant complexity."( Safety assessment of graphene oxide and microcystin-LR complex: a toxicological scenario beyond physical mixture.
Cao, Y; Ding, X; Liu, Q; Ma, Y; Pang, Y; Zhang, T, 2022
)
0.72
"To study the toxic effects of microcystin-LR (MC-LR) on crayfish, adult male Procambarus clarkii were exposed to different concentrations of MC-LR for 96 h."( Acute toxic effects of microcystin-LR on crayfish (Procambarus clarkii): Insights from antioxidant system, histopathology and intestinal flora.
Li, Z; Ren, N; Sun, K; Tian, X; Xu, P; Zhang, Y, 2023
)
0.91
" Although many studies have focused on the toxic effect on fish and mammals exposed to MC-LR, works that incorporate published data into a comprehensive comparison and analysis are still limited."( A meta-analysis on the toxicity of microcystin-LR to fish and mammals.
Li, Y; Xie, P; Zhang, H; Zhao, X, 2023
)
0.91
" Therefore, this study explored the long-term toxic effects and toxic mechanisms of MC-LR on the heart and provided evidence for the induction of cardiovascular disease by MC-LR."( Cardiac Toxicity Induced by Long-Term Environmental Levels of MC-LR Exposure in Mice.
Cao, L; Liu, Y; Massey, IY; Osman, MA; Yan, C; Yang, F; Yang, Y, 2023
)
0.91
"Perfluorooctanoic acid (PFOA) and microcystin-LR (MCLR) are pervasive pollutants in surface waters that induce significant toxic effects on aquatic organisms."( Combined toxic effects of perfluorooctanoic acid and microcystin-LR on submerged macrophytes and biofilms.
Lan, Y; Lei, N; Li, Q; Shen, Y; Wang, Q; Wei, R; Xie, Y; Yang, Y, 2023
)
0.91
" One of the hotspots is toxic mechanisms (indicated by the frequent appearance of oxidative stress, DNA damage, apoptosis, neurotoxicity, genotoxicity, ROS, comet assay, signalling pathway, and gene expression indicate as keywords)."( The mechanisms of microcystin-LR-induced genotoxicity and neurotoxicity in fish and mammals: Bibliometric analysis and meta-analysis.
Xie, P; Zhang, H, 2023
)
0.91
" We first reported that long-term exposure to MC-LR induced gastric toxicity by activating the MAPK signaling pathway, providing a new insight into the gastric toxic mechanisms caused by MC-LR."( Long-Term Exposure to Microcystin-LR Induces Gastric Toxicity by Activating the Mitogen-Activated Protein Kinase Signaling Pathway.
Li, Y; Liu, Y; Lv, Y; Tan, Q; Tang, Y; Yang, F; Yang, Y; Yao, X, 2023
)
0.91
" However, our understanding about the toxic effects of co-exposure of MPs and MCs on male reproduction is limited."( Co-exposure to polystyrene microplastics and microcystin-LR aggravated male reproductive toxicity in mice.
Chen, Y; Ding, J; Han, X; Jin, H; Li, D; Liu, H; Pan, C, 2023
)
0.91
"Microcystin-LR (MCLR) is one of the most toxic cyanobacterial toxins and is harmful to the central nervous system of fish."( Probiotic Lactobacillus rhamnosus alleviates the neurotoxicity of microcystin-LR in zebrafish (Danio rerio) through the gut-brain axis.
Deng, P; Hung, TC; Li, G; Liu, H; Luan, N; Ma, X; Niu, Q; Qin, J; Wang, G; Wu, Q; Yan, W; Zuo, J, 2024
)
1.44

Bioavailability

ExcerptReferenceRelevance
" The results showed that PSNPs could improve the bioavailability of MCLR in the zebrafish liver by acting as a carrier and accelerate MCLR-induced oxidative stress by regulating the levels of corresponding enzymes and genes."( The presence of polystyrene nanoplastics enhances the MCLR uptake in zebrafish leading to the exacerbation of oxidative liver damage.
Hung, TC; Li, G; Ling, X; Nie, H; Pan, M; Shen, J; Yang, Q; Zuo, J, 2022
)
0.72

Dosage Studied

ExcerptRelevanceReference
" Male rats were dosed with toxin as described above, and then animals were dosed in the ileal loop with either cholestyramine resin (CTR, 50 mg/rat) or an equivalent vehicle."( A model system for studying the bioavailability of intestinally administered microcystin-LR, a hepatotoxic peptide from the cyanobacterium Microcystis aeruginosa.
Beasley, VR; Carmichael, WW; Dahlem, AM; Hassan, AS; Swanson, SP, 1989
)
0.28
" doses of microcystin-LR (MCLR) to establish dose-response curves and to determine if a sublethal dose of MCLR would protect against an approximate LD100 min given 2 or 3 days later."( Toxicity of intraperitoneal doses of microcystin-LR in two strains of male mice.
Beasley, VR; Carmichael, WW; Dahlem, AM; Haschek, WM; Hooser, SB; Lovell, RA; Schaeffer, DJ,
)
0.13
" Three sets of experiments were undertaken to investigate the acute toxicity of microcystin-LR in mice and rats by the oral and intraperitoneal routes, the potential for effects on foetal development in the mouse, and the effects of repeated oral dosing over 13 weeks in the mouse."( The toxicity of cyanobacterial toxins in the mouse: I microcystin-LR.
Everett, DJ; Fawell, JK; Hill, RE; Mitchell, RE, 1999
)
0.3
" MCLR was orally dosed at 500 microg/kg to aged Balb/C and ICR mice and their lethality was 23."( First report on the distribution of orally administered microcystin-LR in mouse tissue using an immunostaining method.
Harada, K; Ito, E; Kondo, F, 2000
)
0.31
" Death due to acute MCLR toxicosis in intravascularly dosed swine appears to result from severe intrahepatic hemorrhage, partial obstruction of blood flow through the liver, circulatory shock, severe hypoglycemia, and/or terminal hyperkalemia."( Microcystin-LR decreases hepatic and renal perfusion, and causes circulatory shock, severe hypoglycemia, and terminal hyperkalemia in intravascularly dosed swine.
Beasley, VR; Carmichael, WW; Hoffmann, WE; Holmes, KR; Lovell, RA; Schaeffer, DJ; Walcott, HE, 2000
)
0.31
" The large number of individuals available for the grazer bioassay allowed the determination of dose-response curves of the different microcystins."( High grazer toxicity of [D-Asp(3),(E)-Dhb(7)]microcystin-RR of Planktothrix rubescens as compared to different microcystins.
Blom, JF; Jüttner, F; Robinson, JA, 2001
)
0.31
" Groups of dams dosed with 32-128 microg kg(-1) on gestation days 7-8, 9-10 or 11-12 were allowed to give birth and the growth and development of their pups were followed postnatally."( Lack of teratogenicity of microcystin-LR in the mouse and toad.
Brownie, CF; Chernoff, N; Hall, LL; Herkovits, J; Hunter, ES; Malarkey, D; Marr, M; Rosen, MB,
)
0.13
" The optimal dosage of ferrate 20 mg/l was determined by studying the degradations of total organic carbon (TOC) and MLR at different concentrations of residual Fe."( Photocatalytic detoxification of microcystins combined with ferrate pretreatment.
Qu, J; Wang, Y; Xing, H; Yuan, B, 2002
)
0.31
" The toxin was easily decomposed by oxidation with ferrate, and the stability depended on the dosage of ferrate and pH."( [Degradation of cyanobacterial peptide hepatotoxins by ferrate].
Qu, J; Wang, M; Yuan, B, 2002
)
0.31
" The toxin was easily decomposed by oxidation with ferrate, and the removal efficiency depended on the dosage of ferrate, pH, and contact time."( Removal of cyanobacterial microcystin-LR by ferrate oxidation-coagulation.
Fu, ML; Qu, JH; Yuan, BL, 2002
)
0.31
"These results suggested that MCLR can injure the heart, kidney and the liver in SD rats, and there is a dose-response relationship between MCLR and the toxic effect."( [The acute toxic effects of microcystin LR in SD rats].
Chen, C; Kang, S; Wei, G; Yu, S; Zhang, Z, 2002
)
0.31
" Cell viability was determined by the methylthiazoltetrazolium (MTT) dye assay, reduced GSH was evaluated by enzymatic methods, ROS were evaluated by the dichlorofluorescein diacetate (H2DCF-DA) fluorescent probe and lipid peroxidation by dosing malondialdehyde (MDA) by the thiobarbituric acid method."( Microcystin-LR and nodularin induce intracellular glutathione alteration, reactive oxygen species production and lipid peroxidation in primary cultured rat hepatocytes.
Bouaïcha, N; Maatouk, I, 2004
)
0.32
" In the presence of toxin at high dosage and for long-term exposure, GST and glutathione levels decreased significantly."( Chronic toxicity and responses of several important enzymes in Daphnia magna on exposure to sublethal microcystin-LR.
Chen, W; Gan, N; Ou, D; Song, L, 2005
)
0.33
" Enhanced degradation of microcystin LR was observed with inoculated (1 x 10(6) cell/mL) treatments of river water dosed with microcystin LR (>80% degradation within 2 days) compared to uninoculated controls."( Biodegradation of the cyanobacterial toxin microcystin LR in natural water and biologically active slow sand filters.
Blakeley, RL; Bourne, DG; Jones, GJ; Riddles, P, 2006
)
0.33
" The result shows that,when adding PAC and chlorine at the same point, chlorine can enhance the removal effect of the combined process (about 20%), which may be because the surface of PAC catalyzes the reaction between mirocystin and chlorine molecule, when adding PAC and chlorine at different points, the strengthening effect disappear [chlorine reduces the ability of PAC to microcystins to some extent (5%-10%)], the effect of chlorine to PAC becomes weak when raise the dosage of PAC."( [Effect of chlorine on PAC's ability to adsorb microcystin].
Dong, BZ; Gao, NY; Liu, C; Liu, SQ; Zhao, JF, 2007
)
0.34
" Meanwhile, it can be concluded from the model that: when the initial UV radiation, H2O2 dosage and the ozone dosage were set, pH value and carbonate (or bicarbonate) concentrations were the two main aspects which influenced the reaction rate."( [Modified kinetics model of degradation of MCLR by advanced oxidation process].
Gao, NY; Guo, JW; Li, L; Yin, DD; Zhang, KJ, 2009
)
0.35
" The lowest cytotoxic MCLR concentration varied between 11 and 100 microM depending on the employed cell viability assay and is within the range of MCLR dosage reported to affect other mammalian cell lines."( Comparative study of the cytotoxic effect of microcistin-LR and purified extracts from Microcystis aeruginosa on a kidney cell line.
Alverca, E; Andrade, M; Batoréu, MC; Dias, E; Jordan, P; Pereira, P; Silva, MJ, 2009
)
0.35
" The ozonation reaction was very effective for elimination of microcystin; solutions of concentration up to 5 mg/L MC-LR were totally oxidized by an ozone dosage of 2 mg/L."( Treatment and kinetic study of cyanobacterial toxin by ozone.
Al Momani, FA; Jarrah, N, 2010
)
0.36
"The present study was carried out to examine the dose-response of microcystin-LR (MC-LR) and microcystin-RR (MC-RR) toxicity in adult Danio rerio (zebrafish) under balneation conditions at various time points."( Biochemical response of diverse organs in adult Danio rerio (zebrafish) exposed to sub-lethal concentrations of microcystin-LR and microcystin-RR: a balneation study.
Balasubramanian, R; de la Cruz, AA; Dionysiou, DD; Gong, Z; Hande, MP; Pavagadhi, S, 2012
)
0.38
"0×10(6) cells mL(-1)) and MC-LR release (2-25 μg L(-1)) occurred when the UV-C dosage reached 350 mJ cm(-2)."( Immediate and long-term impacts of UV-C irradiation on photosynthetic capacity, survival and microcystin-LR release risk of Microcystis aeruginosa.
Deng, Y; Gao, N; Ou, H; Qiao, J; Wang, H, 2012
)
0.38
" Moreover, the same dosage of MC-LR increased reactive oxygen species production and malondialdehyde content."( Toxic effects of microcystin-LR on the reproductive system of male Rana nigromaculata in vitro.
Cai, C; Han, L; Jia, X; Shou, X; Wang, J; Wang, M; Wu, Y; Ye, B; Zhang, H, 2013
)
0.39
" Long-time accumulation of even trace dosage from drinking water would cause significantly hepatic injury to animal and humans."( Facile synthesis of Cu(2+)-modified mesoporous silica-coated magnetic graphene composite for enrichment of microcystin-LR followed by mass spectrometry analysis.
Deng, C; Liu, S; Zhang, X, 2016
)
0.43
" Consideration of the ammonia concentration and the chlorine dosage relative to the chlorination breakpoint dosages is important for utilities assessing the impact of prechlorination of water containing cyanobacteria."( Effect of oxidant demand on the release and degradation of microcystin-LR from Microcystis aeruginosa during oxidation.
Adams, CD; Dan, Y; Eichholz, T; Ma, Y; Shi, H; Zhang, H, 2017
)
0.46
" Although the dualistic effects of MCs have been postulated, the specific action mode according to the exposure dosage of MCs remains unknown."( Characterization of Microcystin-Induced Dualistic Toxic Effects on Primary Rat Hepatocytes.
Hong, X; Lou, D; Qian, X; Shuai, Y; Wang, Y; Xiao, P; Yin, J; Zhong, W, 2017
)
0.46
" Samples harvested from six fingerling channel catfish (Ictalurus punctatus) dosed intraperitoneally with a sublethal MC-LR dose of 250 μg/kg were analyzed, and microcystin concentrations ranging from 370 to 670 ng/g in plasma and 566-1030 ng/g in liver were detected."( Analysis of microcystin-LR and nodularin using triple quad liquid chromatography-tandem mass spectrometry and histopathology in experimental fish.
Khoo, L; Kuhn, DD; Mainous, ME; Murphy, L; Smith, S; Steadman, J; Vudathala, D, 2017
)
0.46
" A860 resin exhibited an excellent adsorption capacity of 3800 μg/g; more than 60% of the MCLR removal was achieved within 10 min with a resin dosage of 200 mg/L (∼1 mL/L)."( Simultaneous uptake of NOM and Microcystin-LR by anion exchange resins: Effect of inorganic ions and resin regeneration.
Barbeau, B; Dixit, F; Mohseni, M, 2018
)
0.48
" Optimal flocculation conditions (Tanfloc dosage 10."( Changes in Microcystis aeruginosa cell integrity and variation in microcystin-LR and proteins during Tanfloc flocculation and floc storage.
Hou, J; Wang, C; Wang, P; Wang, X; Yang, Y; Yang, Z, 2018
)
0.48
" We investigate in-situ electrochemically produced ferrate from common carbon steel as an on-demand alternative to crystalline ferrate for the removal of microcystin-LR (MC-LR) and compare the removal efficacy for both electrochemical (EC) and chemical dosing methodologies."( In-situ electrochemical Fe(VI) for removal of microcystin-LR from drinking water: comparing dosing of the ferrate ion by electrochemical and chemical means.
Cataldo, M; Dubrawski, KL; Dubrawski, Z; Mazumder, A; Mohseni, M; Wilkinson, DP, 2018
)
0.48
" Optimum sorption conditions were determined as a function of pH (2-7), adsorbent dosage (0."( Removal of microcystin-LR from aqueous solution using Moringa oleifera Lam. seeds.
Aftab, K; Kashif, M; Yasmin, R, 2019
)
0.51
" CD-1 mice were divided into three dosage groups: control, low exposure (sub-lethal MC-LR concentration), and high exposure (near-lethal MC-LR concentration)."( Acute cyanotoxin poisoning reveals a marginal effect on mouse gut microbiome composition but indicates metabolic shifts related to liver and gut inflammation.
Evans, MV; Knobloch, T; Lee, J; Lee, S; Mills, MC; Weghorst, C, 2021
)
0.62
"Previous studies have primarily concentrated on the hepatotoxicity of MC-LR, whereas its gastric toxicity effects and mechanisms of long-term exposure under low dosage remain unknown."( Long-Term Exposure to Microcystin-LR Induces Gastric Toxicity by Activating the Mitogen-Activated Protein Kinase Signaling Pathway.
Li, Y; Liu, Y; Lv, Y; Tan, Q; Tang, Y; Yang, F; Yang, Y; Yao, X, 2023
)
0.91
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
bacterial metaboliteAny prokaryotic metabolite produced during a metabolic reaction in bacteria.
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitorAny EC 3.1.3.* (phosphoric monoester hydrolase) inhibitor that interferes with the action of phosphoprotein phosphatase (EC 3.1.3.16).
xenobioticA xenobiotic (Greek, xenos "foreign"; bios "life") is a compound that is foreign to a living organism. Principal xenobiotics include: drugs, carcinogens and various compounds that have been introduced into the environment by artificial means.
environmental contaminantAny minor or unwanted substance introduced into the environment that can have undesired effects.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
microcystinA family of cyclic heptapeptide hepatotoxins produced by a number of cyanobacteria, the most notable of which is Microcystis, from which the name of the family is derived. Microcystins consist of a heptapeptide macrocycle made up of five non-protein amino acids and two protein amino acids.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (8)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Tyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)IC50 (µMol)0.00120.00053.49849.7600AID164505
Protein phosphatase 1AHomo sapiens (human)IC50 (µMol)0.00300.00300.00300.0030AID164496
Serine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)IC50 (µMol)0.03020.00000.15921.7800AID200711; AID200712; AID200713; AID200714; AID200715; AID200716; AID200718; AID200719; AID200720; AID200721
Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoformHomo sapiens (human)IC50 (µMol)0.00010.00010.00010.0001AID164526
Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B Gallus gallus (chicken)IC50 (µMol)0.00160.00010.41982.9000AID164673; AID200735
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Solute carrier organic anion transporter family member 1A2Homo sapiens (human)Km20.00006.40007.42009.6000AID679883
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)Km12.40000.03912.93886.4000AID682088
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)Km12.40000.00763.201810.0000AID680550
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (65)

Processvia Protein(s)Taxonomy
positive regulation of JUN kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein dephosphorylationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of signal transductionTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of signal transductionTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
actin cytoskeleton organizationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of endocytosisTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of vascular endothelial growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulum unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of intracellular protein transportTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cellular response to unfolded proteinTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
peptidyl-tyrosine dephosphorylationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
platelet-derived growth factor receptor-beta signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
IRE1-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor recyclingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of MAP kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of type I interferon-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
growth hormone receptor signaling pathway via JAK-STATTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of protein tyrosine kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of ERK1 and ERK2 cascadeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of hepatocyte growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of IRE1-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of PERK-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of receptor catabolic processTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of transcription by RNA polymerase IIProtein phosphatase 1AHomo sapiens (human)
protein dephosphorylationProtein phosphatase 1AHomo sapiens (human)
N-terminal protein myristoylationProtein phosphatase 1AHomo sapiens (human)
protein export from nucleusProtein phosphatase 1AHomo sapiens (human)
dephosphorylationProtein phosphatase 1AHomo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayProtein phosphatase 1AHomo sapiens (human)
negative regulation of BMP signaling pathwayProtein phosphatase 1AHomo sapiens (human)
peptidyl-threonine dephosphorylationProtein phosphatase 1AHomo sapiens (human)
positive regulation of canonical NF-kappaB signal transductionProtein phosphatase 1AHomo sapiens (human)
negative regulation of canonical NF-kappaB signal transductionProtein phosphatase 1AHomo sapiens (human)
positive regulation of DNA-templated transcriptionProtein phosphatase 1AHomo sapiens (human)
positive regulation of protein export from nucleusProtein phosphatase 1AHomo sapiens (human)
regulation of cell cycleProtein phosphatase 1AHomo sapiens (human)
cellular response to transforming growth factor beta stimulusProtein phosphatase 1AHomo sapiens (human)
positive regulation of canonical Wnt signaling pathwayProtein phosphatase 1AHomo sapiens (human)
negative regulation of non-canonical NF-kappaB signal transductionProtein phosphatase 1AHomo sapiens (human)
protein dephosphorylationSerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
MAPK cascadeSerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
blastocyst developmentSerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
glycogen metabolic processSerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
protein dephosphorylationSerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
spermatogenesisSerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
neuron differentiationSerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
circadian regulation of gene expressionSerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
regulation of circadian rhythmSerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
entrainment of circadian clock by photoperiodSerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
regulation of nucleocytoplasmic transportSerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
cell divisionSerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
positive regulation of glial cell proliferationSerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
mitotic sister chromatid segregationSerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
xenobiotic metabolic processSolute carrier organic anion transporter family member 1A2Homo sapiens (human)
monoatomic ion transportSolute carrier organic anion transporter family member 1A2Homo sapiens (human)
organic cation transportSolute carrier organic anion transporter family member 1A2Homo sapiens (human)
organic anion transportSolute carrier organic anion transporter family member 1A2Homo sapiens (human)
bile acid and bile salt transportSolute carrier organic anion transporter family member 1A2Homo sapiens (human)
sodium-independent organic anion transportSolute carrier organic anion transporter family member 1A2Homo sapiens (human)
transmembrane transportSolute carrier organic anion transporter family member 1A2Homo sapiens (human)
protein dephosphorylationSerine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoformHomo sapiens (human)
response to morphineSerine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoformHomo sapiens (human)
xenobiotic metabolic processSolute carrier organic anion transporter family member 1B3Homo sapiens (human)
monoatomic ion transportSolute carrier organic anion transporter family member 1B3Homo sapiens (human)
organic anion transportSolute carrier organic anion transporter family member 1B3Homo sapiens (human)
bile acid and bile salt transportSolute carrier organic anion transporter family member 1B3Homo sapiens (human)
heme catabolic processSolute carrier organic anion transporter family member 1B3Homo sapiens (human)
sodium-independent organic anion transportSolute carrier organic anion transporter family member 1B3Homo sapiens (human)
transmembrane transportSolute carrier organic anion transporter family member 1B3Homo sapiens (human)
xenobiotic metabolic processSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
monoatomic ion transportSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
organic anion transportSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
bile acid and bile salt transportSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
prostaglandin transportSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
heme catabolic processSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
sodium-independent organic anion transportSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
transmembrane transportSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
thyroid hormone transportSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (34)

Processvia Protein(s)Taxonomy
RNA bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
zinc ion bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
enzyme bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein kinase bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
receptor tyrosine kinase bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cadherin bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
ephrin receptor bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein phosphatase 2A bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
non-membrane spanning protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
magnesium ion bindingProtein phosphatase 1AHomo sapiens (human)
protein serine/threonine phosphatase activityProtein phosphatase 1AHomo sapiens (human)
protein bindingProtein phosphatase 1AHomo sapiens (human)
myosin phosphatase activityProtein phosphatase 1AHomo sapiens (human)
manganese ion bindingProtein phosphatase 1AHomo sapiens (human)
calmodulin-dependent protein phosphatase activityProtein phosphatase 1AHomo sapiens (human)
R-SMAD bindingProtein phosphatase 1AHomo sapiens (human)
RNA bindingSerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
phosphoprotein phosphatase activitySerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
protein serine/threonine phosphatase activitySerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
protein bindingSerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
lamin bindingSerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
protein phosphatase 1 bindingSerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
phosphatase activitySerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
myosin phosphatase activitySerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
protein kinase bindingSerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
protein domain specific bindingSerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
protein-containing complex bindingSerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
metal ion bindingSerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
organic anion transmembrane transporter activitySolute carrier organic anion transporter family member 1A2Homo sapiens (human)
organic cation transmembrane transporter activitySolute carrier organic anion transporter family member 1A2Homo sapiens (human)
bile acid transmembrane transporter activitySolute carrier organic anion transporter family member 1A2Homo sapiens (human)
transmembrane transporter activitySolute carrier organic anion transporter family member 1A2Homo sapiens (human)
sodium-independent organic anion transmembrane transporter activitySolute carrier organic anion transporter family member 1A2Homo sapiens (human)
protein bindingSerine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoformHomo sapiens (human)
protein phosphatase regulator activitySerine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoformHomo sapiens (human)
serine-type endopeptidase inhibitor activitySolute carrier organic anion transporter family member 1B3Homo sapiens (human)
organic anion transmembrane transporter activitySolute carrier organic anion transporter family member 1B3Homo sapiens (human)
bile acid transmembrane transporter activitySolute carrier organic anion transporter family member 1B3Homo sapiens (human)
sodium-independent organic anion transmembrane transporter activitySolute carrier organic anion transporter family member 1B3Homo sapiens (human)
organic anion transmembrane transporter activitySolute carrier organic anion transporter family member 1B1Homo sapiens (human)
bile acid transmembrane transporter activitySolute carrier organic anion transporter family member 1B1Homo sapiens (human)
prostaglandin transmembrane transporter activitySolute carrier organic anion transporter family member 1B1Homo sapiens (human)
sodium-independent organic anion transmembrane transporter activitySolute carrier organic anion transporter family member 1B1Homo sapiens (human)
thyroid hormone transmembrane transporter activitySolute carrier organic anion transporter family member 1B1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (32)

Processvia Protein(s)Taxonomy
plasma membraneTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
mitochondrial matrixTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
early endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulumTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytosolTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
mitochondrial cristaTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endosome lumenTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
sorting endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmic side of endoplasmic reticulum membraneTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein-containing complexTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulumTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
early endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
nucleusProtein phosphatase 1AHomo sapiens (human)
nucleoplasmProtein phosphatase 1AHomo sapiens (human)
cytosolProtein phosphatase 1AHomo sapiens (human)
plasma membraneProtein phosphatase 1AHomo sapiens (human)
membraneProtein phosphatase 1AHomo sapiens (human)
nucleusProtein phosphatase 1AHomo sapiens (human)
cytosolProtein phosphatase 1AHomo sapiens (human)
chromosome, telomeric regionSerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
kinetochoreSerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
nucleusSerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
nucleolusSerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
cytoplasmSerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
mitochondrionSerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
mitochondrial outer membraneSerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
microtubule organizing centerSerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
cytosolSerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
focal adhesionSerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
nuclear speckSerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
midbodySerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
cleavage furrowSerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
dendritic spineSerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
presynapseSerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
glutamatergic synapseSerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
protein-containing complexSerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
PTW/PP1 phosphatase complexSerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
nucleusSerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
cytoplasmSerine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)
plasma membraneSolute carrier organic anion transporter family member 1A2Homo sapiens (human)
basal plasma membraneSolute carrier organic anion transporter family member 1A2Homo sapiens (human)
apical plasma membraneSolute carrier organic anion transporter family member 1A2Homo sapiens (human)
basolateral plasma membraneSolute carrier organic anion transporter family member 1A2Homo sapiens (human)
nucleoplasmSerine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoformHomo sapiens (human)
cytosolSerine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoformHomo sapiens (human)
glutamatergic synapseSerine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoformHomo sapiens (human)
protein phosphatase type 2A complexSerine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoformHomo sapiens (human)
cytosolSerine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoformHomo sapiens (human)
plasma membraneSolute carrier organic anion transporter family member 1B3Homo sapiens (human)
basal plasma membraneSolute carrier organic anion transporter family member 1B3Homo sapiens (human)
basolateral plasma membraneSolute carrier organic anion transporter family member 1B3Homo sapiens (human)
plasma membraneSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
basal plasma membraneSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
membraneSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
basolateral plasma membraneSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (37)

Assay IDTitleYearJournalArticle
AID200749Exogenous inhibition concentration of Serine/threonine protein phosphatase 2C (PP2C); NI means no inhibition.2002Journal of medicinal chemistry, Mar-14, Volume: 45, Issue:6
Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies.
AID665869Irreversible inhibition of PP2A using p-NPP as substrate assessed as recovery of enzyme activity pretreated for 1 hr followed by 4 hrs dialysis by spectrophotometry2012Bioorganic & medicinal chemistry, Jun-15, Volume: 20, Issue:12
The structures of three metabolites of the algal hepatotoxin okadaic acid produced by oxidation with human cytochrome P450.
AID680234TP_TRANSPORTER: uptake in Xenopus laevis oocytes2005Toxicology and applied pharmacology, Mar-15, Volume: 203, Issue:3
Organic anion transporting polypeptides expressed in liver and brain mediate uptake of microcystin.
AID682088TP_TRANSPORTER: uptake in Xenopus laevis oocytes2005Toxicology and applied pharmacology, Mar-15, Volume: 203, Issue:3
Organic anion transporting polypeptides expressed in liver and brain mediate uptake of microcystin.
AID681819TP_TRANSPORTER: uptake in Xenopus laevis oocytes2005Toxicology and applied pharmacology, Mar-15, Volume: 203, Issue:3
Organic anion transporting polypeptides expressed in liver and brain mediate uptake of microcystin.
AID441114Cytotoxicity against Wistar rat hepatocytes harboring transporter Oatp1b2 after 90 mins by differential interference contrast microscopy2009Journal of medicinal chemistry, Sep-24, Volume: 52, Issue:18
Acyloxymethyl esterification of nodularin-R and microcystin-LA produces inactive protoxins that become reactivated and produce apoptosis inside intact cells.
AID164673Inhibitory concentration required against protein phosphatase 2A using pNPP assay2003Bioorganic & medicinal chemistry letters, Sep-01, Volume: 13, Issue:17
Linearized and truncated microcystin analogues as inhibitors of protein phosphatases 1 and 2A.
AID200889Exogenous inhibition concentration of Serine/threonine protein phosphatase 5 (PP5)2002Journal of medicinal chemistry, Mar-14, Volume: 45, Issue:6
Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies.
AID200721Inhibition of Serine/threonine protein phosphatase 1 9PP1) mutants by natural toxins in R221S2002Journal of medicinal chemistry, Mar-14, Volume: 45, Issue:6
Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies.
AID441116Cytotoxicity against Wistar rat hepatocytes harboring transporter Oatp1b2 assessed as appearance of polarized cell blebbing at 0.2 uM after 90 mins by differential interference contrast microscopy2009Journal of medicinal chemistry, Sep-24, Volume: 52, Issue:18
Acyloxymethyl esterification of nodularin-R and microcystin-LA produces inactive protoxins that become reactivated and produce apoptosis inside intact cells.
AID1355137Cytotoxicity against human A549 cells assessed as reduction in cell viability after 72 hrs by MTT assay2018Journal of natural products, 06-22, Volume: 81, Issue:6
Microcystins Containing Doubly Homologated Tyrosine Residues from a Microcystis aeruginosa Bloom: Structures and Cytotoxicity.
AID164496Inhibitory concentration required against protein phosphatase 1 using pNPP assay2003Bioorganic & medicinal chemistry letters, Sep-01, Volume: 13, Issue:17
Linearized and truncated microcystin analogues as inhibitors of protein phosphatases 1 and 2A.
AID441118Lipophilicity, logD at pI2009Journal of medicinal chemistry, Sep-24, Volume: 52, Issue:18
Acyloxymethyl esterification of nodularin-R and microcystin-LA produces inactive protoxins that become reactivated and produce apoptosis inside intact cells.
AID588209Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset2010Chemical research in toxicology, Jul-19, Volume: 23, Issue:7
Developing structure-activity relationships for the prediction of hepatotoxicity.
AID200719Inhibition of Serine/threonine protein phosphatase 1 (PP1) mutants by natural toxins in Y272F2002Journal of medicinal chemistry, Mar-14, Volume: 45, Issue:6
Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies.
AID200713Inhibition of Serine/threonine protein phosphatase 1 (PP1) mutants by natural toxins in D220V2002Journal of medicinal chemistry, Mar-14, Volume: 45, Issue:6
Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies.
AID679416TP_TRANSPORTER: uptake in Xenopus laevis oocytes2005Toxicology and applied pharmacology, Mar-15, Volume: 203, Issue:3
Organic anion transporting polypeptides expressed in liver and brain mediate uptake of microcystin.
AID679883TP_TRANSPORTER: uptake in Xenopus laevis oocytes2005Toxicology and applied pharmacology, Mar-15, Volume: 203, Issue:3
Organic anion transporting polypeptides expressed in liver and brain mediate uptake of microcystin.
AID200715Inhibition of Serine/threonine protein phosphatase 1 (PP1) mutants by natural toxins in H248N2002Journal of medicinal chemistry, Mar-14, Volume: 45, Issue:6
Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies.
AID200718Inhibition of Serine/threonine protein phosphatase 1 (PP1) mutants by natural toxins in R96A2002Journal of medicinal chemistry, Mar-14, Volume: 45, Issue:6
Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies.
AID164505Observed inhibition activity of the compounds against protein phosphatases 1 (PP1)1997Journal of medicinal chemistry, Sep-26, Volume: 40, Issue:20
A model for binding of structurally diverse natural product inhibitors of protein phosphatases PP1 and PP2A.
AID200751Exogenous inhibition concentration of Serine/threonine protein phosphatase 4 (PP4)2002Journal of medicinal chemistry, Mar-14, Volume: 45, Issue:6
Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies.
AID164497Ratio of IC50 of Protein phosphatase 1 to that of IC50 of Protein phosphatase 2A2003Bioorganic & medicinal chemistry letters, Sep-01, Volume: 13, Issue:17
Linearized and truncated microcystin analogues as inhibitors of protein phosphatases 1 and 2A.
AID200712Inhibition of Serine/threonine protein phosphatase 1 (PP1) mutants by natural toxins in D208A2002Journal of medicinal chemistry, Mar-14, Volume: 45, Issue:6
Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies.
AID200711Inhibition of Serine/threonine protein phosphatase 1 (PP1) mutants by natural toxins in C127S2002Journal of medicinal chemistry, Mar-14, Volume: 45, Issue:6
Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies.
AID200714Inhibition of Serine/threonine protein phosphatase 1 (PP1) mutants by natural toxins in E275R2002Journal of medicinal chemistry, Mar-14, Volume: 45, Issue:6
Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies.
AID1355136Cytotoxicity against human HCT116 cells assessed as reduction in cell viability after 72 hrs by MTT assay2018Journal of natural products, 06-22, Volume: 81, Issue:6
Microcystins Containing Doubly Homologated Tyrosine Residues from a Microcystis aeruginosa Bloom: Structures and Cytotoxicity.
AID200735Exogenous inhibition concentration of Serine/threonine protein phosphatase 2A (PP2A)2002Journal of medicinal chemistry, Mar-14, Volume: 45, Issue:6
Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies.
AID441113Induction of apoptosis in Swiss mouse 3T3 cells assessed as appearance of apoptotic morphology at 100 uM injected directly into intact cells after 3 hrs by Hoechst 33342 staining-based fluorescence microscopy in presence of esterase2009Journal of medicinal chemistry, Sep-24, Volume: 52, Issue:18
Acyloxymethyl esterification of nodularin-R and microcystin-LA produces inactive protoxins that become reactivated and produce apoptosis inside intact cells.
AID441119Lipophilicity, logD at pH 7.42009Journal of medicinal chemistry, Sep-24, Volume: 52, Issue:18
Acyloxymethyl esterification of nodularin-R and microcystin-LA produces inactive protoxins that become reactivated and produce apoptosis inside intact cells.
AID680550TP_TRANSPORTER: uptake in Xenopus laevis oocytes2005Toxicology and applied pharmacology, Mar-15, Volume: 203, Issue:3
Organic anion transporting polypeptides expressed in liver and brain mediate uptake of microcystin.
AID588210Human drug-induced liver injury (DILI) modelling dataset from Ekins et al2010Drug metabolism and disposition: the biological fate of chemicals, Dec, Volume: 38, Issue:12
A predictive ligand-based Bayesian model for human drug-induced liver injury.
AID164526Observed inhibition activity of the compounds against protein phosphatases 2A (PP2A)1997Journal of medicinal chemistry, Sep-26, Volume: 40, Issue:20
A model for binding of structurally diverse natural product inhibitors of protein phosphatases PP1 and PP2A.
AID200716Inhibition of Serine/threonine protein phosphatase 1 (PP1) mutants by natural toxins in N124D2002Journal of medicinal chemistry, Mar-14, Volume: 45, Issue:6
Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies.
AID200720Inhibition of Serine/threonine protein phosphatase 1 (PP1) mutants by natural toxins in wild type2002Journal of medicinal chemistry, Mar-14, Volume: 45, Issue:6
Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies.
AID200561Exogenous inhibition of Serine/threonine protein phosphatase 1 (PP1)2002Journal of medicinal chemistry, Mar-14, Volume: 45, Issue:6
Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies.
AID681645TP_TRANSPORTER: uptake in Xenopus laevis oocytes2005Toxicology and applied pharmacology, Mar-15, Volume: 203, Issue:3
Organic anion transporting polypeptides expressed in liver and brain mediate uptake of microcystin.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (1,509)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (0.73)18.7374
1990's159 (10.54)18.2507
2000's383 (25.38)29.6817
2010's705 (46.72)24.3611
2020's251 (16.63)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 8.59

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index8.59 (24.57)
Research Supply Index7.34 (2.92)
Research Growth Index5.93 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (8.59)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.07%)5.53%
Reviews25 (1.63%)6.00%
Case Studies4 (0.26%)4.05%
Observational0 (0.00%)0.25%
Other1,503 (98.04%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]